These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
68 related items for PubMed ID: 16170959
1. [Epidemiologic and situational panorama of hepatitis C in Mexico]. Vera de León L, Juárez Navarro JA, Díaz Gómez M, Méndez Navarro J, Chirino Sprung RA, Dehesa Violante M, Casillas Davila L, Rizo Robles MT, Torres Ibarra R, Cano Domínguez C, Nava Estrada J, Ramos Gómez M, Hernández ME, Wong González S, Félix Tamayo M, Corona Lechuga Mdel C, Zárate Negrete AR, Rangel Jiménez M, Rodríguez Hernández H, González Ortiz V, Tirado Estrella MP, Villanueva Carreto ML, Orta Flores R, Manteca Argumedo JL, Vázquez Avila I, González Macias J, Razcón Hernández O, Torres López P, Bazán Pérez C. Rev Gastroenterol Mex; 2005; 70(1):25-32. PubMed ID: 16170959 [Abstract] [Full Text] [Related]
2. Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico. Rodríguez-Pérez F, Suárez-Pérez E, Alvarez-Rohena M, Toro DH. P R Health Sci J; 2004 Jun; 23(2 Suppl):49-56. PubMed ID: 16929587 [Abstract] [Full Text] [Related]
5. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C. Zografos TA, Liaskos C, Rigopoulou EI, Togousidis E, Makaritsis K, Germenis A, Dalekos GN. Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648 [Abstract] [Full Text] [Related]
6. Chronic hepatitis C virus infection in renal transplant: treatment and outcome. Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N. Clin Transplant; 2006 Mar; 20(6):677-83. PubMed ID: 17100715 [Abstract] [Full Text] [Related]
13. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in Western Turkey. Altuglu I, Soyler I, Ozacar T, Erensoy S. Int J Infect Dis; 2008 May; 12(3):239-44. PubMed ID: 17942359 [Abstract] [Full Text] [Related]
15. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan. Yu ML, Lin SM, Chuang WL, Dai CY, Wang JH, Lu SN, Sheen IS, Chang WY, Lee CM, Liaw YF. Antivir Ther; 2006 May; 11(8):985-94. PubMed ID: 17302368 [Abstract] [Full Text] [Related]
16. [Changes in socio-economics, quality of life and knowledge of patients with chronic hepatitis C during the Hepatitis Competence Net Project]. Niederau C, Bemba G, Kautz A. Z Gastroenterol; 2008 Jan; 46(1):22-33. PubMed ID: 18188813 [Abstract] [Full Text] [Related]